AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
We enclose a copy of the press release that is being issued by the Company in connection with announcement by Curateq Biologics Private Limited, a wholly owned subsidiary of the Company on positive results in Phase 3 clinical trial for its proposed Trastuzub Biosimilar Product. AUROBINDO PHARMA LTD. - 524804 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
This is to inform that the Company has entered into an agreement with Viatris Inc., of certain marketing and manufacturing related authorisations. AUROBINDO PHARMA LTD. - 524804 - Information Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Completion of sale and transfer of all equity shares held by Aurobindo Pharma Limited in Auro Vaccines Private Limited, a WOS, to CuraTeQ Biologics Private Limited, another WOS.
Aurobindo Pharma share price falls as US FDA uncovers fresh faults at Anakapalli facility
US Food and Drug Administration officials found multiple faults at a plant run by Aurobindo Pharma as the watchdog continues to unearth wide-ranging lapses across the country's factories while working through a pandemic-era inspection backlog. AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
This is to inform that the officials of the Company will be participating in the investor / analyst meetings on June 30, 2023. AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
This is to inform that the officials of the Company will be participating in the investor / analyst meetings on June 30, 2023. AUROBINDO PHARMA LTD. - 524804 - Auro PR Inc, Puerto Rico Is Undertaking A Restructuring Of Its Facility To Enhance Production Volume
Auro PR Inc., Puerto Rico is undertaking a restructuring of its facility to enhance production volume AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
This is to inform that the officials of the Company will be participating in the investor / analyst meetings in Hyderabad on June 27, 2023. AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
This is to inform that the officials of the Company will be participating in the investor / analyst meetings in Hyderabad on June 26, 2023.